1) erdosteine
厄多司坦
1.
Clinical Study of Erdosteine in the Assistance Treatment of Radiation Pneumonitis;
厄多司坦辅助治疗放射性肺炎的临床观察
2.
Study on mutagenicity of Erdosteine;
厄多司坦致突变作用研究
3.
The Effects and Mechanisms of Aminoguanidine and Erdosteine in Bleomycin-induced Pulmonary Fibrosis in Rats;
氨基胍和厄多司坦对博莱霉素致大鼠肺纤维化的干预作用及机制
2) ambroxol erdosteinate
厄多司坦氨溴索
3) fudosteine
福多司坦
1.
Determination of fudosteine in human serum by LC-MS/MS:application to relative bioavailability of two domestic preparations;
福多司坦胶囊和片剂人体生物等效性评价
2.
Determination of related substances in Fudosteine capsules by HPLC;
高效液相色谱法测定福多司坦胶囊的有关物质
3.
Pharmacokinetic study of fudosteine in healthy volunteers;
福多司坦片在健康志愿者中的药代动力学研究
4) fudosteine
弗多司坦
1.
A randomized controlled trial of fudosteine versus ambroxol in patients with respiratory tract infection as an expectorant;
弗多司坦对呼吸道感染病人祛痰作用的随机对照临床研究
5) Fudostein Tablets
福多司坦片
1.
Determination of Fudostein Tablets by RP-HPLC;
反相高效液相色谱法测定福多司坦片的含量
6) irbesartan
厄贝沙坦
1.
Determination of Irbesartan Sustained Tablets by HPLC;
高效液相色谱法测定厄贝沙坦缓释片的含量
2.
Study on the Pharmacokinetics and Relative Bioavailability of Irbesartan Orally Disintegrating Tablets in Healthy Volunteers;
厄贝沙坦口腔崩解片健康受试者体内的药动学及生物等效性研究
3.
Effect of Irbesartan on the level of serum high-sensitivity C-reactive protein in patients with acute cerebral infarction;
厄贝沙坦对急性脑梗死患者血清超敏C反应蛋白水平的影响
补充资料:厄多司坦
分子式:C8H11NO4S2
分子量:249.3
CAS号:84611-23-4
性质:白色或类白色结晶性粉末,无异臭
制备方法:暂无
用途:祛痰药物中间体
分子量:249.3
CAS号:84611-23-4
性质:白色或类白色结晶性粉末,无异臭
制备方法:暂无
用途:祛痰药物中间体
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条